MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Randomized controlled trial of 1Hz SMA rTMS + gait training for Freezing of Gait

    G. Revuelta, D. Lench, C. Hanlon, A. Hydar, W. Devries, S. Kautz (Charleston, SC, USA)

    Objective: To determine the effects of 1Hz supplementary motor area (SMA) repetitive transcranial magnetic stimulation (rTMS) and gait training on freezing of gait (FOG). Background:…
  • 2019 International Congress

    DBS for PD in Albania

    I. Zekja, R. Alimehmeti, F. Dashi, S. Grabova, M. Petrela, M. Rralacolli, J. Kruja (Tirana, Albania)

    Objective: DBS: surgical procedure of choice for PD. Albanian experience. Background: Parkinson disease (PD) : the decrease of dopamine’s levels because of nigro – striatal…
  • 2019 International Congress

    Oromandibular Dystonia as an Initial Manifestation of Parkinson’s Disease: 2 Case Reports

    F. Gao (San Francisco, CA, USA)

    Objective: We describe an unusual initial manifestation of Parkinson’s disease, consisting of oromandibular dystonia. We also discuss the role of DaTscan SPECT imaging in the…
  • 2019 International Congress

    Diagnosing Dementia with Lewy Bodies – Characterizing the prevalence and underlying relationships between core and supportive clinical features

    E. Matar, K. Ehgoetz Martens, G. Halliday, S. Lewis (Sydney, Australia)

    Objective: To characterize the interrelationship between core and supportive features of Dementia with Lewy Bodies, and identify optimal methods for their detection to inform better…
  • 2019 International Congress

    Accelerometer-Based Gait Analysis for Patients with Parkinson’s Disease

    S-T. Tang, C-H. Tai, Y-H. Lai, T-C. Lee (Taoyuan, Taiwan)

    Objective: The study is to develop an accelerometer-based gait analysis for the patients with Parkinson’s disease, which would provide timely complete gait information following the…
  • 2019 International Congress

    Quantification of regional iron content with Susceptibility Weighted Imaging in Huntington Disease Expansion Gene Carriers

    ER. de Natale, H. Wilson, G. Dervenoulas, F. Niccolini, SJ. Tabrizi, M. Politis (London, United Kingdom)

    Objective: To assess brain iron content measured with SWI-MRI in HD gene expansion carriers (HDGECs). Background: Huntington’s Disease (HD) results in extensive neuronal cell loss,…
  • 2019 International Congress

    Normative Curves for Selected Unified Huntington Disease Rating Scale Measures

    J. Mills, J. Long, A. Mohan, J. Ware, C. Sampaio (Iowa City, IA, USA)

    Objective: To examine the effects of natural aging for those without Huntington disease (HD) gene expansion and to develop normative curves by age, sex, and…
  • 2019 International Congress

    Subcortical atrophy is an early event in Huntington’s disease

    N. Rocha, L. Latham, O. Charron, G. Papadimitropoulos, G. Colpo, L. Freeman, E. Furr Stimming, A. Teixeira (Houston, TX, USA)

    Objective: To determine whether brain regional volumes are associated with clinical symptoms in premanifest and manifest Huntington’s disease (HD). Background: Striatal atrophy has been considered a…
  • 2019 International Congress

    Long-term levodopa-carbidopa intestinal infusion in Parkinson’s disease: survival and mortality

    CA. Artusi, R. Balestrino, G. Imbalzano, S. Bortolani, S. Tuttobene, E. Montanaro, M. Zibetti, L. Lopiano (Torino, Italy)

    Objective: We sought to analyze the mortality and the causes of death of 105 patients with Parkinson disease (PD) treated with levodopa-carbidopa intestinal gel (LCIG)…
  • 2019 International Congress

    Randomized, placebo-controlled, double-blind, two-period cross-over study to evaluate the safety, tolerability, and efficacy of a novel treatment combination for levodopa induced dyskinesia in Parkinson’s Disease (BUS-PD)

    K. Chung, B. Lobb, S. O'Connor (Portland, OR, USA)

    Objective: To evaluate the efficacy of buspirone in combination with amantadine in reducing levodopa-induced dyskinesia (LID) in patients with Parkinson’s disease (PD). Background: LID is…
  • « Previous Page
  • 1
  • …
  • 68
  • 69
  • 70
  • 71
  • 72
  • …
  • 217
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • #23285 (not found)
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley